Elevation Insights™ | Pfizer IP/Patent Expirations This presentation highlights some of Pfizer's major drugs that face IP expiration and upcoming intense competition from Generics. This presentation will be useful for Alliance, Collaboration (Drug Discovery & Development) & Licensing partners who can judge the vulnerability of Pfizer and their urgent need to replenish their pipeline.